Formulary Search
A to Z of Drugs : P
Records returned : 195 (on 28 May 2025 at 05:00:13).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Service not currently provided by Surrey Heartlands Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
restricted antimicrobial for paediatric use, to be used on the advice of microbiologist
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Used in
- hypercalcaemia of malignancy
- bone metastases
- prevention of skeletal events
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Prescribe by brand - product with multiple ingredients. GP initiation following specialist recommendation.
Nutrizym recommended in pregnancy / breastfeeding due to theoretical concern of phthalate content of Creon.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Powder
Restrictions / Comments:
Important
Prescribe by brand - product with multiple ingredients. GP initiation following specialist recommendation.
SASH restrict to tube-fed patients only (Pancrex V powder)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
1st-line IV PPI at ASPH, 2nd-line at RSFT
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
1st-line IV PPI at ASPH, 2nd-line at RSFT
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Granules
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Effervescent tablets
- Soluble tablets
- Suppositories
Restrictions / Comments:
Important
Reserve for patients who cannot swallow solid dose forms.
Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets.
Suppositories for use when oral route is not suitable
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms or where sodium content of dispersible preparations is a problem.
Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Prescribe in milligrams for doses <1g.
Review infusion prescriptions after 48-72 hours.
Note risk of overdose with IV paracetamol.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Effervescent tablets
- Soluble tablets
- Suppositories
Restrictions / Comments:
Important
Reserve for patients who cannot swallow solid dose forms.
Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms. Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Prescribe in milligrams for doses <1g
Review infusion prescriptions after 48-72 hours.
Note risk of overdose with IV paracetamol.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye ointment
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye ointment
Restrictions / Comments:
Important
Moderate dry eye.
Prescribe by brand:
1st line = HydraMed Night
2nd line = Moistueyes, Xailin Night, Hylo Night
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Rectal solution
Restrictions / Comments:
Important
Unlicensed product. Paediatrics only.
GPs may continue prescribing for EXISTING patients where they are satisfied that it is safe to do so.
Prescribing for new patients should remain with the initiating, specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
To be used in intractable cancer pain only.
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
For acromegaly: Commissied by NHSE from specialist centres only. Not provided by Surrey Heartlands Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
RSFT only - commissioned as a Specialised Endocrinology Centre
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Visualisation of sentinel lymph node biopsy in breast surgery
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Peak flow meters - low range /
Peak flow meters - standard range
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Refer to St Luke's Protocols for current indications and further detail.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
RESTRICTED - to be used under advice from Consultant Microbiologist
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
For acromegaly: Commissied by NHSE from specialist centres only. Not provided by Surrey Heartlands Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Severe disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Hepatology only - under local shared care arrangements with specialist input.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Nebules
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Urology consultants only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Restricted to Oral Surgeons only - with Vitamin E to start 1 week before extraction and for 3 months after (until good healing is observed)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
The gastro-resistant capsules (Mintec®) are the most cost-effective option for Primary Care.
The modified-release capsules (Colpermin) contain arachis oil - not be taken by patients with a known peanut allergy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
RSFT - gynaecology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Suspension
Restrictions / Comments:
Important
RSCH use in children age 6-12 years only.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Requires specialist initiation and supply for at least 12 weeks prior to a transfer of care to primary care prescribers
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not a 1st-line treatment option.
On-going toxicity monitoring required
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2mg, 4mg and 8mg tablets. Do not prescribe as perindopril arginine.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2mg, 4mg and 8mg tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Acute pain, including obstetric analgesia
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Subcutaneous infusion
Restrictions / Comments:
Important
Off-label. Specialist use only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Elixir
- Tablets
Restrictions / Comments:
Important
Ensure that the patient is maintained on a specific manufacturer’s product
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
Ensure that the patient is maintained on a specific manufacturer’s product
Unlicensed phenobarbital liquid 50mg/5ml (sugar and alcohol free) for paediatric use (as recommended by the RCPCH and NPPG).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Unlicensed.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Poisoning with clonidine or MAOIs or sympathothomimetic drugs of abuse
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ophthalmic insert
Restrictions / Comments:
Important
MYDRIASERT 5.4mg/0.28mg Ophthalmic Insert
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intraocular irrigation
Restrictions / Comments:
Important
This drug has not yet been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to the APC.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Ensure that the patient is maintained on a specific manufacturer’s product.
Phenytoin sodium is NOT EQUIVALENT to Phenytoin base (suspension). When switching between products, 100mg of phenytoin sodium is approximately equivalent to 92mg of phenytoin base.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Linctus
- Mixture
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enema
Restrictions / Comments:
Important
Contraindicated in patients with CKD, dehydration and heart failure (among others).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
ASPH use for colon capsule endoscopy only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Treatment of dry eye and dry mouth in Sjögren's syndrome.
For initiation and stabilisation for 3 months by the specialist team before any request to transfer prescribing to primary care.
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
4% eye drops used orally - off-label use.
Prescribing by primary care on recommendation from specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free)
Restrictions / Comments:
Important
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Contra-indicated in Penicillin Allergy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Preferred
0.5% gel.
Low cost option for primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
QVH = local sleep specialist centre
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Review existing patients and consider alternative.
Discontinuation of pizotifen requires gradual withdrawal.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
This drug has not yet been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to the APC.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Endotracheopulmonary suspension
Restrictions / Comments:
Important
Administered by endotracheal tube.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Effervescent tablets
- Oral solution
Restrictions / Comments:
Important
Can be purchased from a pharmacy
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
65mg tablets. Tablets can be quartered.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pessaries
- Vaginal gel
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
- Eye drops (preservative free
- unit dose)
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
https://www.toxbase.org. Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Preferred
Patients with severe symptoms, who are obese, co-morbid depression, increased risk of falls or cognitive impairment
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Initiation on specialist recommendation only. For severe dryness where other treatments are ineffective / contraindicated.
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to cardiology consultants. Clopidogrel is the preferred option.
Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Only the 500mcg tablets are licensed in the UK. 2mg and 5mg tablets as special order or import only (much more expensive)
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
For patients unable to swallow solid dose forms.
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
For use in patients who are unable to swallow solid dose forms. Request for primary care prescribing after initiation and stabilisation - at least 1 month supply from specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enteric coated tablets
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
For patients unable to swallow solid dose forms.
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
For use in patients who are unable to swallow solid dose forms. Request for primary care prescribing after initiation and stabilisation - at least 1 month supply from specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enteric coated tablets
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
0.5%, 1% drops. Short-term use only.
Primary Care prescribing on specialist recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Tablets can be dispersed for immediate administration.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
Paediatrics only at SASH.
Paediatrics and oncology at ASPH
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Paediatric doses and NG/NJ tube only
Links :
Indication :
Status :
Formulations :
- Gastro-resistant tablets
Restrictions / Comments:
Important
Enteric coated tablets - non-formulary
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Foam enema
Restrictions / Comments:
Important
Budesonide rectal foam is preferred.
Steroid safety considerations
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
Not a preferred formulation. Ordinary tablets can be dispersed in water. Only use a dispersible tablet where a patient is unable to disperse an ordinary tablet.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Reserved for patients with fine bore NG tube or patients who require doses of less than 5mg which could otherwise be obtained from a dispersing an ordinary 5mg tablet.
An option in paeds who cannot tolerate the taste of dispersible tablets.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enteric coated tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Important
Prednisolone sodium phosphate 0.5% ear drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Capsules are more cost effective than tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Off-label use.
Off-label use
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Not for chronic or acute, non-malignant pain. See separate formulary entry for use in neuropathic pain
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Gabapentin is preferred due to lower potential for misuse.
Pregabalin capsules more cost effective than tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Patients with severe sleep disturbance, RLS-related / co-morbid pain or history of impulse control disorder
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Solution for injection
Restrictions / Comments:
Important
Injection prior to LLETZ procedure or cervical biopsy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribe by brand - ensure patient is maintained on a specific product.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation by specialist before transfer to Primary Care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Named-patient supply only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Unlicensed
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Buccal tablets
- Intramuscular injection (IM)
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Oral solution for patients with swallowing difficulties.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
1st line treatment option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Buccal/sublingual
Restrictions / Comments:
Important
An option for patients with swallowing difficulties
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Buccal tablets
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ointment
- Suppositories
Restrictions / Comments:
Important
Scheriproct ointment and suppositories are considerably less expensive than Proctosedyl, Uniroid and Anusol HC
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Intravenous injection (IV)
- Tablets
Restrictions / Comments:
Important
Primary Care prescribing on advice from palliative care specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
https://www.toxbase.org/
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Specialist team initiation and stabilisation. At least 1 month supply before request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Prescribe generically.
Micronised progesterone oral capsules.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Progesterone pessaries have not been agreed for use as endometrial protection.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Initiation by specialist team before any request is made for primary care prescribing.
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Initiation by specialist team before any request is made for primary care prescribing.
Links :
Indication :
Status :
Formulations :
- Vaginal capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Off-label use. In women who experience bleeding in early pregnancy and those who have miscarried previously. Specialist only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Oral solution for patients with swallowing difficulties.
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
1st line treatment option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
An option for patients with swallowing difficulties
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
1st line treatment option.
This is a lower cost promethazine option for primary care but note difference in CKS recommended dose.
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
This is a lower cost promethazine option for primary care but note difference in recommended doses between teoclate and hydrochloride salts
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
0.1% eye drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Hyoscine butylbromide is the preferred treatment option for smooth muscle spasm.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Palliative Care Team only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Palliative Care Team only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Oral solution
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Oral solution
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Oral solution
- Tablets
Restrictions / Comments:
Important
Not a preferred beta blocker for hypertension. The cardio-selective betablockers, bisoprolol or atenolol are the preferred options
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Oral solution
- Tablets
Restrictions / Comments:
Important
Only in combination with an alpha-blocker.
Transfer of prescribing to primary care only after initiation and stabilisation by the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Heparin reversal.
Heamtology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Warfarin reversal - restricted to Haematology & ICU Consultants
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
0.5% preservative free eye drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Endoscopy use only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Only after a trial of at least 2 other classes of laxative at the highest recommended, tolerated doses. Consider stopping after 4 weeks if not effective.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Linctus
- Liquid
- Oral solution
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Note MHRA/CHM safety advice.
As per CKS for upper airway cough syndrome (post-nasal drip) after other treatments and investigations have failed.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
3rd line. Off-label use for patients who have not responded to midodrine or fludrocortisone
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
https://www.toxbase.org/ . Unlicensed
https://www.toxbase.org/
Formulary Status :
Links :